GB9801871D0 - Therapies - Google Patents
TherapiesInfo
- Publication number
- GB9801871D0 GB9801871D0 GBGB9801871.6A GB9801871A GB9801871D0 GB 9801871 D0 GB9801871 D0 GB 9801871D0 GB 9801871 A GB9801871 A GB 9801871A GB 9801871 D0 GB9801871 D0 GB 9801871D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/08—Sphingolipids
- G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801871.6A GB9801871D0 (en) | 1998-01-28 | 1998-01-28 | Therapies |
PCT/GB1999/000290 WO1999038530A1 (en) | 1998-01-28 | 1999-01-28 | Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder |
AU22900/99A AU2290099A (en) | 1998-01-28 | 1999-01-28 | Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder |
CA002318190A CA2318190A1 (en) | 1998-01-28 | 1999-01-28 | Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder |
EP99902688A EP1049489A1 (en) | 1998-01-28 | 1999-01-28 | Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801871.6A GB9801871D0 (en) | 1998-01-28 | 1998-01-28 | Therapies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9801871D0 true GB9801871D0 (en) | 1998-03-25 |
Family
ID=10826080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9801871.6A Ceased GB9801871D0 (en) | 1998-01-28 | 1998-01-28 | Therapies |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1049489A1 (en) |
AU (1) | AU2290099A (en) |
CA (1) | CA2318190A1 (en) |
GB (1) | GB9801871D0 (en) |
WO (1) | WO1999038530A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513733D0 (en) * | 1995-07-05 | 1995-09-06 | Univ Bristol | Therapeutic agents |
CA2163716C (en) * | 1995-11-24 | 2009-05-19 | Clifford A. Lingwood | Verotoxin pharmaceutical compositions and medical treatments therewith |
US5801145A (en) * | 1996-02-09 | 1998-09-01 | Ontario Cancer Institute | Method for selectively purging CD77+ cells from bone marrow |
WO1998051326A1 (en) * | 1997-05-16 | 1998-11-19 | Hsc Research And Development Limited Partnership | Inhibition of angiogenesis by verotoxins |
-
1998
- 1998-01-28 GB GBGB9801871.6A patent/GB9801871D0/en not_active Ceased
-
1999
- 1999-01-28 AU AU22900/99A patent/AU2290099A/en not_active Abandoned
- 1999-01-28 WO PCT/GB1999/000290 patent/WO1999038530A1/en not_active Application Discontinuation
- 1999-01-28 EP EP99902688A patent/EP1049489A1/en not_active Withdrawn
- 1999-01-28 CA CA002318190A patent/CA2318190A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2318190A1 (en) | 1999-08-05 |
AU2290099A (en) | 1999-08-16 |
WO1999038530A1 (en) | 1999-08-05 |
EP1049489A1 (en) | 2000-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69909613D1 (en) | Bicyclische hydroxamsäurederivate | |
DE69924108D1 (en) | Offshore-bohrsystem | |
DE59912932D1 (en) | Arylphenylsubstituierte cyclische ketoenole | |
DE59912303D1 (en) | Arylphenylsubstituierte cyclische ketoenole | |
GB2339200B (en) | Genostics | |
DE69918845D1 (en) | Polyketonlösung | |
DE69913545D1 (en) | Pyrimidonderivate | |
GB0116362D0 (en) | Ammumition | |
GB9909064D0 (en) | Therapies | |
DE69943409D1 (en) | Fmcw-radar | |
DE69904335D1 (en) | Aminomethylcarbonsäurederivate | |
DE69835235D1 (en) | Thermoplastische silikonelastomere | |
DE69940558D1 (en) | Fluoromonomerpolymerisation | |
DE59903023D1 (en) | Perorale wirkstoff-suspension | |
DE59914151D1 (en) | Arylalkanoylpyridazine | |
DE69908871D1 (en) | Thermisch härtbare glasplatte | |
DE69934603D1 (en) | Elektrophotographischer photoconduktor | |
DE69915628D1 (en) | Ritonavir-polymorph | |
DE69938146D1 (en) | Ptc-chip-thermistor | |
DE69904442D1 (en) | Cyclohexandiol-derivate | |
DE69905001D1 (en) | Koagulationsvorrichtung | |
GB2339642B (en) | Earphone-microphone-earmuff-assembly | |
DE69925859D1 (en) | Cycloalkylsubstituierte aminomethylpyrrolidin-derivate | |
GB2337049B (en) | Trisresorcinyltriazines | |
EP1059091A4 (en) | Transmucous sorbefacients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |